18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease–Associated Retinal Hemangioblastoma

Georgios Z. Papadakis, Corina Millo, Inderbir S. Jassel, Ulaş Bağcı, Samira M. Sadowski, Apostolos H. Karantanas, Nicholas J. PatronasClinical 2016 · DOI

Abstract

Retinal hemangioblastomas are highly vascular benign tumors that can be encountered either sporadically or within the von Hippel-Lindau (VHL) syndrome. We report a case of a VHL patient with retinal hemangioblastoma who underwent PET/CT scans using 18F-FDG and 68Ga-DOTATATE. The tumor showed low-level 18F-FDG and increased 68Ga-DOTATATE activity, suggesting cell-surface overexpression of somatostatin receptors. The presented case indicates the clinical applications of somatostatin receptor imaging with 68Ga-DOTA–conjugated peptides in detection and follow-up of VHL manifestations, screening of asymptomatic gene carriers, and in diagnosis of sporadic retinal hemangioblastomas, which may have similar features on MRI with other retinal tumors.
BibTeX
@inproceedings{papadakis2016f,
  author = {Georgios Z. Papadakis and Corina Millo and Inderbir S. Jassel and Ulaş Bağcı and Samira M. Sadowski and Apostolos H. Karantanas and Nicholas J. Patronas},
  title = {{18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease–Associated Retinal Hemangioblastoma}},
  booktitle = {Clinical},
  year = {2016},
  doi = {10.1097/rlu.0000000000001511},
}

Loading related content...

Figure